Antidepressant self-discontinuation: Results from the collaborative psychiatric epidemiology surveys

Psychiatric Services

Volumn 66, Issue 5, 2015, Pages 455-462

  Samples, Hillary ^a   Mojtabai, Ramin ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE; AGED; AGORAPHOBIA; ALCOHOL ABUSE; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DRUG DEPENDENCE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSTHYMIA; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MEDICAID; MEDICARE; PANIC; PATIENT ATTITUDE; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; SELF CARE; SELF DISCONTINUATION; SOCIAL PHOBIA; TREATMENT DURATION; TREATMENT WITHDRAWAL; ADOLESCENT; CLINICAL PRACTICE; COOPERATION; DEPRESSIVE DISORDER; FEMALE; MALE; MIDDLE AGED; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; COOPERATIVE BEHAVIOR; DEPRESSIVE DISORDER; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRACTICE PATTERNS, PHYSICIANS'; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84928885727     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201400021     Document Type: Article

References (49)

1. Trivedi MH, Rush AJ, Wisniewski SR, et al: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗D: implications for clinical practice. American Journal of Psychiatry 163:28-40, 2006
2. Arroll B, Macgillivray S, Ogston S, et al: Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Annals of Family Medicine 3:449-456, 2005
3. van der Linden GJ, Stein DJ, van Balkom AJ: The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials. International Clinical Psychopharmacology 15(suppl 2):S15-S23, 2000
4. Cipriani A, Furukawa TA, Salanti G, et al: Comparative efficacy and acceptability of 12 new-generation antidepressants: a multipletreatments meta-analysis. Lancet 373:746-758, 2009
5. Clum GA, Clum GA, Surls R: A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology 61: 317-326, 1993
6. Young AS, Klap R, Sherbourne CD, et al: The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry 58:55-61, 2001
7. Olfson M, Marcus SC, Tedeschi M, et al: Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry 163:101-108, 2006
8. Rush AJ: STAR∗D: what have we learned? American Journal of Psychiatry 164:201-204, 2007
9. Serna MC, Cruz I, Real J, et al: Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. European Psychiatry 25:206-213, 2010
10. Wu CH, Erickson SR, Piette JD, et al: The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Research in Social and Administrative Pharmacy 8:193-205, 2012
11. Rivero-Santana A, Perestelo-Perez L, Perez-Ramos J, et al: Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies. Journal of Patient Preference and Adherence 7:151-169, 2013
12. Samples H, Mojtabai R: Antidepressant use in the European Union: perceived indications and patterns. Psychiatric Services 64: 208, 2013
13. Montgomery SA, Henry J, McDonald G, et al: Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. International Clinical Psychopharmacology 9:47-53, 1994
14. Hunot VM, Horne R, Leese MN, et al: A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Primary Care Companion to the Journal of Clinical Psychiatry 9:91-99, 2007
15. Milea D, Guelfucci F, Bent-Ennakhil N, et al: Antidepressant monotherapy: a claims database analysis of treatment changes and treatment duration. Clinical Therapeutics 32:2057-2072, 2010
16. Tanno S, Ohhira M, Tsuchiya Y, et al: Frequent early discontinuation of SSRI prescribed by primary care physicians in young males in Japan. Internal Medicine 48:1263-1266, 2009
17. Trifirò G, Tillati S, Spina E, et al: A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. European Journal of Clinical Pharmacology 69:227-236, 2013
18. Hansen RA, Dusetzina SB, Dominik RC, et al: Prescription refill records as a screening tool to identify antidepressant non-adherence. Pharmacoepidemiology and Drug Safety 19:33-37, 2010
19. Heeringa SG, Wagner J, Torres M, et al: Sample designs and sampling methods for the Collaborative Psychiatric Epidemiology Studies (CPES). International Journal of Methods in Psychiatric Research 13:221-240, 2004
20. Kessler RC, Merikangas KR: The National Comorbidity Survey Replication (NCS-R): background and aims. International Journal of Methods in Psychiatric Research 13:60-68, 2004
21. Jackson JS, Torres M, Caldwell CH, et al: The National Survey of American Life: a study of racial, ethnic and cultural influences on mental disorders and mental health. International Journal of Methods in Psychiatric Research 13:196-207, 2004
22. Alegria M, Takeuchi D, Canino G, et al: Considering context, place and culture: the National Latino and Asian American Study. International Journal of Methods in Psychiatric Research 13:208-220, 2004
23. Pennell BE, Bowers A, Carr D, et al: The development and implementation of the National Comorbidity Survey Replication, the National Survey of American Life, and the National Latino and Asian American Survey. International Journal of Methods in Psychiatric Research 13:241-269, 2004
24. Mojtabai R, Olfson M: National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the National Comorbidity Survey Replication. Journal of Clinical Psychiatry 69:1064-1074, 2008
25. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
26. Wittchen HU: Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. Journal of Psychiatric Research 28:57-84, 1994
27. Stata Statistical Software: Release 12. College Station, Tex, Stata Corp, 2011
28. Katon W, von Korff M, Lin E, et al: Adequacy and duration of antidepressant treatment in primary care. Medical Care 30:67-76, 1992
29. Altshuler L, Suppes T, Black D, et al: Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. American Journal of Psychiatry 160:1252-1262, 2003
30. Littrell J: Relationship between time since reuptake-blocker antidepressant discontinuation and relapse. Experimental and Clinical Psychopharmacology 2:82, 1994
31. Geddes JR, Carney SM, Davies C, et al: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361:653-661, 2003
32. Middleton DJ, Cameron IM, Reid IC: Continuity and monitoring of antidepressant therapy in a primary care setting. Quality in Primary Care 19:109-113, 2011
33. Stein MB, Cantrell CR, Sokol MC, et al: Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Psychiatric Services 57:673-680, 2006
34. Brambilla P, Cipriani A, Hotopf M, et al: Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry 38:69-77, 2005
35. Bull SA, Hu XH, Hunkeler EM, et al: Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 288:1403-1409, 2002
36. Frank RG, Glied S: Better but Not Well: Mental Health Policy in the United States Since 1950. Baltimore, Johns Hopkins University Press, 2006
37. Olfson M, Marcus SC: National patterns in antidepressant medication treatment. Archives of General Psychiatry 66:848-856, 2009
38. Cooper LA, Gonzales JJ, Gallo JJ, et al: The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Medical Care 41:479-489, 2003
39. Peveler R, George C, Kinmonth AL, et al: Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. British Medical Journal 319:612-615, 1999
40. Mojtabai R, Olfson M: National trends in long-term use of antidepressant medications: results from the US National Health and Nutrition Examination Survey. Journal of Clinical Psychiatry 75: 169-177, 2014
41. Boudreau DM, Daling JR, Malone KE, et al: A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. American Journal of Epidemiology 159:308-317, 2004
42. Haukka J, Suvisaari J, Tuulio-Henriksson A, et al: High concordance between self-reported medication and official prescription database information. European Journal of Clinical Pharmacology 63:1069-1074, 2007
43. Cotterchio M, Kreiger N, Darlington G, et al: Comparison of self-reported and physician-reported antidepressant medication use. Annals of Epidemiology 9:283-289, 1999
44. Sarangarm P, Young B, Rayburn W, et al: Agreement between selfreport and prescription data in medical records for pregnant women. Birth Defects Research: Part A, Clinical and Molecular Teratology 94:153-161, 2012
45. Haapea M, Miettunen J, Lindeman S, et al: Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort. International Journal of Methods in Psychiatric Research 19:88-96, 2010
46. Tisnado DM, Adams JL, Liu H, et al: What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Medical Care 44:132-140, 2006
47. Kwon A, Bungay KM, Pei Y, et al: Antidepressant use: concordance between self-report and claims records. Medical Care 41:368-374, 2003
48. Boudreau DM, Doescher MP, Saver BG, et al: Reliability of Group Health Cooperative automated pharmacy data by drug benefit status. Pharmacoepidemiology and Drug Safety 14:877-884, 2005
49. Sun GC, Hsu MC, Moyle W, et al: Mediating roles of adherence attitude and patient education on antidepressant use in patients with depression. Perspectives in Psychiatric Care 47:13-22, 2011